This article has Open Peer Review reports available.
Epidemiology of childhood Guillan-Barre syndrome in the north west of Iran
© Barzegar et al; licensee BioMed Central Ltd. 2007
Received: 05 March 2007
Accepted: 05 August 2007
Published: 05 August 2007
Background and aims
This study was carried out to investigate the incidence, annual time trend and some epidemiological and clinical features of Guillain-Barre syndrome in children in the north west of Iran.
Materials and methods
In this population-based cross sectional research, epidemiological and clinical features of 143 cases with Guillain-Barre syndrome between 2001 and 2006 were studied. The setting of the study was Tabriz Children Medical Centre, the major University-Hospital located in Tabriz city of the East Azarbaijan province covering whole region. Data collected included age, gender, chronological information, preceding events, functional grade of motor deficit.
The mean age (standard deviation) of subjects was 5.4 (3.6) years. The male/female ratio was 1.3. The average annual incidence rate was 2.27 per 100 000 population of 15 years children (CI95%: 1.9–2.6). The majority of cases occurred in March, July and November and the highest proportion of the syndrome was observed in winter (29 percent, P > 0.10).
The results indicated that an unexpected high incidence of Guillain-Barre syndrome has occurred in 2003 in the region. We concluded that a monitoring and surveillance system for Guillain-Barre syndrome is essential to set up in this region.
Guillain-Barre syndrome is an autoimmune disorder of peripheral nervous system causing progressive weakness and areflexia. Since the marked decline in poliomyelitis incidence, the syndrome is now the most common cause of acute flaccid paralysis in many countries . Epidemiologic studies have reported an annual incidence of 0.16–4 (mostly between 1–2) cases per 100 000 population from different countries [2–10]. Although the disease is considered to be sporadic without significant variation over time, some studies have shown annual and seasonal trends [5–8, 11–13].
The aim of this study was to investigate the incidence, annual time trend and some epidemiological and clinical features of Guillain-Barre syndrome in children in the north west of Iran.
East Azerbaijan is located in the northwest of Iran, a cold climate zone. It has a total area of 47 821 km2. According to the official census data, the total population of children 0–15 years was estimated 6465267 over the study period.
In this population-based cross sectional research, medical history and clinical features of 143 cases with Guillain-Barre syndrome between 2001 and 2006 were studied. The setting of the study was Tabriz Children Medical Centre, is the largest children medical center in the north-west area of Iran. This medical centre is a 200-bed acute care university hospital providing tertiary referral care for critically ill patients.
As part of World Health Organization's (WHO) certification process for polio eradication, Iran has been systematically registering children under 15 years old with acute flaccid paralysis since 1995. However, the local policy for acute flaccid paralysis (AFP) surveillance program is that all cases of AFP should be referred to Tabriz Children Medical Centre. All subjects are routinely examined by expert child neurologist (Mohammad Barzegar, the principal investigator of this project) within 7 days of notification. The GBS cases (under 16 years) were then diagnosed and aascertained based on the criteria defined and introduced by Asbury and Cornblath .
Data collected included age, gender, chronological information, preceding events, neurological features functional grade of motor deficit and laboratory findings. The functional status at the time of maximum deficit was graded according to Hughes scale of disability as follows: 0: healthy, 1: minor signs and symptoms and is capable of running; 2: able to walk 5 meters without assistance, but is unable to run. 3: able to walk with assistance, 4: confined to bed or chair bound, 5: requires assisted ventilation, and 6: died .
Poliovirus infection was excluded by cultures that are routinely performed for patients with acute flaccid paralysis as a requirement of the national program of poliomyelitis eradication.
All children underwent at least one electro diagnostic evaluation at the acute phase of disease (from day 1 to 27, average 6.5 days). A Medelec Synergy electromyography machine was used for this assessment. Nerve conduction studies included motor nerve conduction (MNC), sensory nerve conduction (SNC), and F-wave response studies were performed using the standard techniques of supramaximal percutaneous nerve stimulation and surface electrode recording. MNC studies were done on the ulnar, tibial and deep peroneal nerves and SNC on median and sural nerves. Each value of nerve conduction was compared with age matched normal data reported by Parano and colleagues . Needle EMG was done for any denervation and motor unit action potential changes in all patients in at least two proximal and two distal limb muscles. Patients were classified as having axonal or demyelinating type based on the electrodiagnostic criteria reported by Cornblath and colleagues . For each patient, the first neurophysiologic study was reviewed.
Approval for this study was obtained from National Public Health Management Centre of Tabriz University of Medical Sciences where a funded project is routinely assessed/approved in terms of methodology, ethical and financial issues.
Incidence rates and descriptive statistics were calculated to document the epidemiological features of the Guillain-Barre syndrome in the area. Data from the Ministry of Health, Statistics Office, were used to estimate the expected frequencies of the syndrome in the East Azarbaijan province to assess the time trend.
Between 2001 and 2006, one hundred forty three cases of Guillain-Barre syndrome were diagnosed and ascertained in Tabriz Children university-hospital of Tabriz University of Medical Sciences, East Azarbaijan province, Iran.
Basic and clinical characteristics of the study subjects with Guillain-Barre syndrome
Median time to peak disability(days)
Upper Respiratory infection
Cranial nerve Involvement
Sensory symptoms (limbs pain)
Upper respiratory tract infections were most common preceding infection in winter (72.5%). Sensory symptoms, mostly as limbs pain were observed in 43 patients (30.1%). Cranial nerve involvement was also observed in about 40% of patients. Bulbar weakness (22%) was the most common type of cranial nerve involvement followed by facial palsy (17%).
The average annual incidence rate was 2.27 per 100 000 population of 15 years children (CI95%: 1.9–2.6) in the area ranging from 1.5 to 3.4 in different years.
Incidence of the Guillain-Barre syndrome in the north west of Iran
Incidence (per 100 000)
95% Confidence Intervals
We investigated the incidence, annual time trend and occurrence of Guillain-Barre syndrome in children in the north west of Iran.
Tabriz Children Hospital is the reference inpatient center for child neurology in the north-west of Iran. Therefore it is unlikely that patients with suspected Guillain-Barre syndrome were not visited/diagnosed/ascertained at this medical centre. However it is possible that some cases may have been missed, especially those with minor clinical signs and symptoms (grade 1) not requiring hospitalization. In our research, clinical features and incidence rate were similar to those reported from other studies [2–6, 8, 10–13].
In our study, the average incidence rate was slightly higher than those reported from most areas in the world (within the range between 0.16 to 4 cases per 100 000). However if we exclude the cases from year 2003, our incidence rate decrease to 2 cases per 100 000 population which is consistent with other reports [5–8, 11, 12].
The highest incidence in the year 2003 could not be related to any pathogen agent as campylobacter jejuni is not routinely detected in our medical centre. However in an investigation carried out by authors from January 2003 to march 2005 in the same region, serological evidence of recent campylobacter jejuni infection was found in about half of children with Guillain-Barre syndrome .
Outbreaks of the disease have been reported from different areas in the last few decades. Investigators from Greece have reported an outbreak in year 2002 . A similar feature was studied/reported in Sweden in 1985 and 1992 . An increased incidence of Guillain-Barre syndrome in the USA for 1976 was attributed to 'swine flu" vaccines . Another study from Caribbean island of Curacao showed that incidence rose sharply from 1.62 (per 100 000) between 1987 and 1991 to 3.10 (per 100 000) between 1992 and 1999 .
Although the disease is considered to be sporadic without significant variation between seasons and months, small clusters occurred in March, July and November and the highest proportion of the syndrome was observed in the winter. Small clusters have been associated with outbreaks of bacterial enteritis caused by contaminated water. A research report from China indicated that summer epidemics of the syndrome might be caused by campylobacter jejuni infection . In a study from Saudi Arabia, analysis of seasonal incidence has also shown that 40% of the cases occurred in the cold seasons with the highest peak in February . In our study, clustering of patients in winter could be related to the high frequency of upper respiratory infection during cold season.
In the time period of 2002–3, a similar high frequency of Guillain-Barre syndrome was reported from the whole country (including neighboring provinces of study area). In seeking to explain this pattern, possible impact of some environmental causal or influencing factors can not be ruled out. More studies are needed to investigate the etiology of this time pattern.
The epidemiology of GBS is not easy to investigate because of the difficulties in case definition and the absence of a reference standard diagnostic test. Furthermore, objective physiologic abnormalities of nerve dysfunction may be difficult to detect at early stages. The difference in the incidence rates reported from different regions might then be partly explained by case definition, the design and methodology of the investigations (i.e. study design, population based vs hospital based settings, case ascertainment, etc).
In conclusion, this study showed an unexpected occurrence of Guillain-Barre syndrome in the area and the whole country for 2003 indicating the necessity of an epidemiological surveillance system in the region for proper intervention in possible outbreaks in the future.
Authors wish to thank the parents of study patients for their assistance in this study. We also thank the National Public Health Management Centre of Tabriz University of Medical Sciences for funding this project.
- Asbury AK, Cornblath DR: Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann neurol. 1990, 27 (suppl): S21-S24. 10.1002/ana.410270707.View ArticlePubMedGoogle Scholar
- Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology: A prospective study on the incidence and prognosis of Guillain-Barre' syndrome in Emilia-Romagna region, Italy (1992–1993). Neurology. 1997, 48: 214-21.View ArticleGoogle Scholar
- Sedano MJ, Calleja J, Canga E, Berciano J: Guillain-Barre syndrome in Cantabria, Spain. An epidemiological and clinical study. Acta Neurol Scand. 1994, 89 (4): 287-92.View ArticlePubMedGoogle Scholar
- Rees JH, Thompson RD, Smeeton NC, Hughes RA: Epidemiological study of Guillain-Barre' syndrome in southeast England. J Neurol Neurosurg Psychiatry. 1998, 64 (1): 74-7.View ArticlePubMedPubMed CentralGoogle Scholar
- Markoula S, Giannopoulos S, Sarmas I, Tzavidi S, Kyritsis AP, Lagos G: Guillain-Barre' syndrome in northwest Greece. Acta Neurol Scand. 2007, 115 (3): 167-73. 10.1111/j.1600-0404.2006.00731.x.View ArticlePubMedGoogle Scholar
- Bogliun G, Beghi E: Italian GBS Registry Study Group. Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996. Acta Neurol Scand. 2004, 110 (2): 100-6. 10.1111/j.1600-0404.2004.00272.x.View ArticlePubMedGoogle Scholar
- Cheng Q, Jiang G-X, Fredrikson S, Link H, de Pedro-Cuesta J: Epidemiological surveillance of Guillain-Barre syndrome in Sweden, 1996-1997. Network members of the Swedish GBS Epidemiology Study Group. Acta Neurol Scand. 2000, 101 (2): 104-10. 10.1034/j.1600-0404.2000.101002104.x.View ArticlePubMedGoogle Scholar
- Hughes RA, Rees JH: Clinical and epidemiologic features of Guillain-Barre syndrome. J Infect Dis. 1997, 176 (Suppl 2): S92-8.View ArticlePubMedGoogle Scholar
- Cheng Q, Wang DS, Jiang GX, Han H, Zhang Y, Wang WZ, Fredrikson S: Distinct pattern of age-specific incidence of Guillain -Barre syndrome in Harbin, China. J Neurol. 2002, 249: 25-32. 10.1007/PL00007844.View ArticlePubMedGoogle Scholar
- Olive JM, Castil OC, Castro RG, Qaudros CA: Epidemiologic study of Guillain-Barre syndrome in children less than 15 years of ages in Latin America. J Infec Dis. 1997, 175 (suppl 1): 160-164.View ArticleGoogle Scholar
- Cheng BC, Chang WN, Chang CS, Chee CY, Huang CR, Chen JB, et al: Guillain-Barre syndrome in southern Taiwan:clinical features, prognostic factors and therapeutic outcomes. European Journal of Neurology. 2003, 10: 655-662. 10.1046/j.1468-1331.2003.00683.x.View ArticlePubMedGoogle Scholar
- Bahou YG, Biary N, AL Deep S: Guillain-Barre syndrome: a series observed at Riyadh Armed Forces Hospital January 1984-january 1994. J Neurol. 1996, 243: 147-152. 10.1007/BF02444006.View ArticlePubMedGoogle Scholar
- Cheng Q, Wang DS, Jiang GX, Han H, Zhang Y, Wang WZ, Fredrikson S: Prospective study of clinical epidemiology of Guillain-Barre syndrome in Harbin, China. J neurol sci. 2003, 215: 63-69. 10.1016/S0022-510X(03)00187-4.View ArticlePubMedGoogle Scholar
- Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM: Controlled trial of prednisolone in acute polyneuropathy lanct. 1978, 2 (8093): 750-3.Google Scholar
- Parano E, Uncini A, Devivo DC, Lovelace RE: Electrophysiologic correlates of peripheral nervous system maturation in infancy and childhood. J Child Neurol. 1993, 8 (4): 336-8.View ArticlePubMedGoogle Scholar
- Cornblath DR, Mellits ED, Griffin JW, Mckhann GM, Albers JW, Miller RG, et al: Motor conduction studies in Guillain barre syndrome: description and prognostic value. J Ann Neurol. 1988, 23 (4): 354-9. 10.1002/ana.410230407.View ArticleGoogle Scholar
- Barzegar M, Alizadeh A, Toopchizadeh V, Dastgiri S, Majidi J: Association of Campylobacter jejuni infection and Guillain-Barre syndrome: a cohort study in North West of Iran. Turkish journal of Pediatrics in press.Google Scholar
- Jiang G-X, Cheng Q, De Pedro-Cuesta J: Basic for public health surveillance of Guillain-Barre syndrome in Sweden. Eur J Public Health. 1998, 8: 197-202. 10.1093/eurpub/8.3.197.View ArticleGoogle Scholar
- Langmuir AD, Bregman DJ, Kurland LT, Nathanson N, Victor M: An epidemiologic and clinical evaluation of GUillain-Barre syndrome reported in association with administration of swine influenza vaccines. Am J Epidemiol. 1984, 119 (6): 841-879.PubMedGoogle Scholar
- Van Koningsveld R, Rico R, Gerstenbluth I, Schmitz PI, Ang CW, Merks IS, et al: Gastroenteritis associated Guillain-Barre syndrome on the Caribbean island Curacao. Neurology. 2001, 56 (11): 1467-1472.View ArticlePubMedGoogle Scholar
- Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, et al: Guillain-Barre syndrome in northern China :relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain. 1995, 118: 597-605. 10.1093/brain/118.3.597.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2377/7/22/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.